SGLT2 inhibitors have a unique diuretic mechanism thought to be one of the reasons for cardiovascular benefits in patients with HF; thus, we summarise the following cardiovascular protective mechanisms associated with diuresis caused by SGLT2 inhibitors (Figure 2). Here, SLC5A2 is linked to hydrops fetalis.